INTERNATIONAL PATENT: SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH FILES APPLICATION FOR "THERAPEUTIC USE OF A MONOCLONAL MOUSE IGG ANTIBODY DIRECTED AGAINST HUMAN GLYCOPROTEIN IB"

Posted On: 2025-11-24

GENEVA, Nov. 24 -- SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH (Emil-von-Behring-Str. 7635041 Marburg) filed a patent application (PCT/EP2025/062572) for "THERAPEUTIC USE OF A MONOCLONAL MOUSE IGG ANTIBODY DIRECTED AGAINST HUMAN GLYCOPROTEIN IB" on May 08, 2025. With publication no. WO/2025/237796, the details related to the patent application was published on Nov 20, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): PATZKE, Juergen (Zum Neuen Hieb 2935043 Marburg)

Abstract: The present invention relates to a monoclonal mouse IgG antibody against human glycoprotein Ib (GPIb) for therapeutic ...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

INTERNATIONAL PATENT: SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH FILES APPLICATION FOR "THERAPEUTIC USE OF A MONOCLONAL MOUSE IGG ANTIBODY DIRECTED AGAINST HUMAN GLYCOPROTEIN IB"